Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,717,460
-
Share change
-
+624,143
-
Total reported value
-
$22,476,000
-
Price per share
-
$3.35
-
Number of holders
-
32
-
Value change
-
+$2,127,045
-
Number of buys
-
18
-
Number of sells
-
10
Institutional Holders of TRACON PHARMACEUTICALS INC - COM (TCON) as of Q4 2017
As of 31 Dec 2017 TRACON PHARMACEUTICALS INC - COM (TCON) had 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,717,460 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, Candriam Luxembourg S.C.A., X-Square Capital, LLC, QVT Financial LP, Alyeska Investment Group, L.P., and RAYMOND JAMES & ASSOCIATES.
This table shows 32 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.